Goldfinch Bio Initiates Phase 1 Clinical Trial of GFB-887 for Kidney Disease
–First-in-Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GFB-887, a Targeted Podocyte-protective Therapeutic for the treatment of Focal…
Pharmaceuticals, Biotechnology and Life Sciences
–First-in-Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GFB-887, a Targeted Podocyte-protective Therapeutic for the treatment of Focal…
–First-in-Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GFB-887, a Targeted Podocyte-protective Therapeutic for the treatment of Focal…
DUBLIN–(BUSINESS WIRE)–The “Global Histology and Cytology Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies…
SUMMIT, N.J.–(BUSINESS WIRE)–$CELG #MS–Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review…
SUMMIT, N.J.–(BUSINESS WIRE)–$CELG #MS–Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review…
– Ziva Cooper, Ph.D. and Mallory Loflin, Ph.D. become latest members of the renowned group of FSD Scientific Advisors led by Charles Pollack, Jr. MD,…
– Ziva Cooper, Ph.D. and Mallory Loflin, Ph.D. become latest members of the renowned group of FSD Scientific Advisors led by Charles Pollack, Jr. MD,…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB: ASPCF) (“Acerus” or the “Company”) today announced that it has reached a mutual agreement…
Thursday programming will emphasize personalized medicine for oncology, rare disease clinical trials and biotech venture capitalism PHILADELPHIA–(BUSINESS WIRE)–The 2019 BIO…
DUBLIN–(BUSINESS WIRE)–The “Global Pharmacogenomics Market: Focus on Services, Applications, Technologies, End Users, Country Data (16 Countries), and Competitive Landscape –…